![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 5, 3674-3682, February 2, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§ and
¶
From the The c-myb proto-oncogene product
(c-Myb) is a sequence-specific DNA-binding protein that functions as a
transcriptional activator. The transcriptional coactivator CREB-binding
protein (CBP) binds via its KIX domain to the activation domain
of c-Myb and mediates c-Myb-dependent transcriptional
activation. CBP possesses intrinsic histone acetyltransferase activity,
and can acetylate not only histones but also certain transcriptional
factors such as GATA1 and p53. Here we demonstrate that the C/H2 domain
of CBP, which is critical for the acetyltransferase activity, also
directly interacts with the negative regulatory domain (NRD) of c-Myb. Consistent with this observation, CBP acetylated c-Myb in
vitro at Lys438 and Lys441 within
the NRD. In addition, CBP acetylated c-Myb in vivo not only
at the sites found in this study but also at the p300-induced acetylation sites reported recently. Replacement of lysine by arginine
at all of these sites dramatically decreased the
trans-activating capacity of c-Myb. The results of
transcriptional activation assays with c-Myb acetylation site mutants
suggested that acetylation of c-Myb at each of these five sites
synergistically enhances c-Myb activity. Mutations of these acetylation
sites reduced the strength of the interaction between c-Myb and CBP.
Thus, acetylation of c-Myb by CBP increases the
trans-activating capacity of c-Myb by enhancing its
association with CBP. These results demonstrate a novel molecular
mechanism of regulation of c-Myb activity.
Laborartory of Molecular Genetics, RIKEN
Tsukuba Institute and the ¶ CREST (Core Research for Evolutional
Science and Technology) Research Project of JST (Japan Science and
Technology Corporation), 3-1-1 Koyadai, Tsukuba,
Ibaraki 305-0074, Japan
To whom correspondence should be addressed: Laboratory of
Molecular Genetics, RIKEN Tsukuba Institute, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan. Tel.: 81-298-36-9031; Fax: 81-298-36-9030; E-mail: sishii@rtc.riken.go.jp.
This article has been cited by other articles:
![]() |
E. Shang, H. D. Nickerson, D. Wen, X. Wang, and D. J. Wolgemuth The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation Development, October 1, 2007; 134(19): 3507 - 3515. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saether, T. Berge, M. Ledsaak, V. Matre, A. H. Alm-Kristiansen, O. Dahle, F. Aubry, and O. S. Gabrielsen The Chromatin Remodeling Factor Mi-2{alpha} Acts as a Novel Co-activator for Human c-Myb J. Biol. Chem., May 11, 2007; 282(19): 13994 - 14005. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sramko, J. Markus, J. Kabat, L. Wolff, and J. Bies Stress-induced Inactivation of the c-Myb Transcription Factor through Conjugation of SUMO-2/3 Proteins J. Biol. Chem., December 29, 2006; 281(52): 40065 - 40075. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurahashi, T. Nomura, C. Kanei-Ishii, Y. Shinkai, and S. Ishii The Wnt-NLK Signaling Pathway Inhibits A-Myb Activity by Inhibiting the Association with Coactivator CBP and Methylating Histone H3 Mol. Biol. Cell, October 1, 2005; 16(10): 4705 - 4713. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lei, J. J. Rushton, L. M. Davis, F. Liu, and S. A. Ness Positive and Negative Determinants of Target Gene Specificity in Myb Transcription Factors J. Biol. Chem., July 9, 2004; 279(28): 29519 - 29527. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hayakawa, M. Towatari, Y. Ozawa, A. Tomita, M. L. Privalsky, and H. Saito Functional regulation of GATA-2 by acetylation J. Leukoc. Biol., March 1, 2004; 75(3): 529 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Gaillard, E Le Rouzic, C Creminon, and B Perbal Alteration of C-MYB DNA binding to cognate responsive elements in HL-60 variant cells Mol. Pathol., October 1, 2002; 55(5): 325 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bies, J. Markus, and L. Wolff Covalent Attachment of the SUMO-1 Protein to the Negative Regulatory Domain of the c-Myb Transcription Factor Modifies Its Stability and Transactivation Capacity J. Biol. Chem., March 8, 2002; 277(11): 8999 - 9009. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bergholtz, T. O. Andersen, K. B. Andersson, J. Borrebak, B. Luscher, and O. S. Gabrielsen The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties Nucleic Acids Res., September 1, 2001; 29(17): 3546 - 3556. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Masumi and K. Ozato Coactivator p300 Acetylates the Interferon Regulatory Factor-2 in U937 Cells following Phorbol Ester Treatment J. Biol. Chem., June 8, 2001; 276(24): 20973 - 20980. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Monroy, D. D. Ruhl, X. Xu, D. K. Granner, P. Yaciuk, and J. C. Chrivia Regulation of cAMP-responsive Element-binding Protein-mediated Transcription by the SNF2/SWI-related Protein, SRCAP J. Biol. Chem., October 26, 2001; 276(44): 40721 - 40726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Jacob, J. Lund, P. Martinez, and L. Hedin Acetylation of Steroidogenic Factor 1 Protein Regulates Its Transcriptional Activity and Recruits the Coactivator GCN5 J. Biol. Chem., September 28, 2001; 276(40): 37659 - 37664. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |